在乳腺癌中PRMT1和PRMT5的作用
Sébastien Martinez1,2, Stéphanie Sentis1,2, Coralie Poulard1,2
1Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, F-69000 Lyon, France.
International journal of molecular sciences
|August 29, 2024
概括
蛋白质氨酸甲基转移酶 (PRMT) 调节乳腺癌的发展. PRMT1和PRMT5是治疗乳腺癌的关键点,乳腺癌是一种异质且往往无法治愈的疾病.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 乳腺癌是全球女性癌症死亡的主要原因.
- 这是一种异质性疾病,具有不同的亚型和治疗策略.
- 表观遗传修饰,包括氨酸甲基化,在乳腺癌的发病和进展中起作用.
研究的目的:
- 提供关于蛋白质氨酸甲基转移酶 (PRMT) 如何调节乳腺癌的最新概述.
- 要突出PRMT1和PRMT5在乳腺瘤发生中的作用.
- 确定PRMT1和PRMT5作为乳腺癌的潜在治疗点.
主要方法:
- 关于PRMT和乳腺癌的当前科学文献的综述.
- 分析PRMT1和PRMT5影响信号通路的机制.
- 通过PRMT1和PRMT5.5调节的关键基质和通路的识别.
主要成果:
- PRMT1和PRMT5是乳腺癌中涉及的信号通路的关键调节者.
- 这些酶影响细胞增殖,细胞亡和DNA修复等关键过程.
- 异常的PRMT活性与乳腺瘤发育的各个阶段有关.
结论:
- PRMT1和PRMT5是乳腺癌的重要调节剂.
- 准PRMT1和PRMT5为乳腺癌治疗提供了一个有前途的治疗策略.
- 对PRMT介导的表观遗传修饰进行进一步的研究对于新型癌症疗法是有必要的.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K


